• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » research-update

Articles Tagged with ''research-update''

Defining a Role for Nutrition in Managing Children With ADHD

August 1, 2017
Jean Baker, MS, RD.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Jean Baker, MS, RD. Ms. Baker has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Parents of kids with ADHD often ask about the role of diet and nutrition in their child’s symptoms, and research has uncovered some interesting possibilities. For example, there is some evidence that concentrations of long-chain polyunsaturated fatty acids (LC-PUFAs, which includes omega-3 fatty acids) may be lower in people with ADHD.
Read More

Is Minocycline Effective When Added to Risperidone for Autism Spectrum Disorder?

August 1, 2017
Shirley Y. Tsai, PharmD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Shirley Y. Tsai, PharmD Candidate (2018) Ms. Tsai has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Why would an antibiotic be helpful in psychiatry? Minocycline crosses the blood-brain barrier and may have neuroprotective effects. A recent study tested whether minocycline might be useful as an adjunct to risperidone for ASD.
Read More

Do Prizes for Abstinence Increase Sobriety in People With Serious Mental Illness?

August 1, 2017
Daniel Carlat, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Daniel Carlat, MD Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Although studies have demonstrated the effectiveness of contingency management (CM) for illicit drug use, there’s less evidence for treatment of alcoholism—in part because a standard breathalyzer has a short detection window of 12 hours, meaning patients must only abstain from drinking since the previous night to pass the test.
Read More

MOXO-CPT: Short and Sweet, but Is It Useful?

June 1, 2017
Kirsten Pickard, BA.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Kirsten Pickard, BA. Ms. Pickard has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Diagnosing ADHD continues to be difficult, time-consuming, and expensive. Having an “objective,” valid test for ADHD would be of value to clinicians and families alike. Continuous performance tests (CPT) are gaining popularity as a complement to clinical examination, rating scales, and interviews with parents and teachers.
Read More

Can a One-Week Naltrexone Detox Reduce Outpatient Opioid Relapse Rates?

May 1, 2017
Kirsten Pickard, BA
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Kirsten Pickard, BA Ms. Pickard has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Naltrexone is an opioid blocker that is FDA-approved for the treatment of alcoholism. However, it is also effective off-label for treating opioid use disorder. The medication comes in two forms: an oral pill (brand name ReVia) and an injectable version (XR naltrexone, or Vivitrol). XR naltrexone is composed of 380 mg of naltrexone, given as an intramuscular injection once a month. During that month, patients who try to use opioids will feel little if any high. This works well to prevent relapse if patients keep getting the shot.
Read More

Computer Games: Good for Cognitive Disorders?

May 1, 2017
Kirsten Pickard
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Kirsten Pickard Ms. Pickard has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We’ve all seen the ads from companies such as Lumosity implying that fun, computer-based learning games will help your mind work better. Such methods are called computerized cognitive training (CCT), and past systematic reviews have had weaknesses, such as combining CCT with other interventions or including studies that were not randomized controlled trials. These researchers performed a systematic review that was more rigorous.
Read More

SSRIs and Bipolar Switching: Evidence of Safety

May 1, 2017
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Editor-in-chief, TCPR Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Do antidepressants cause bipolar II patients to switch from depression to hypomania? It’s a controversial question, and you’ll find academic psychiatrists who will argue passionately that antidepressants are either safe or dangerous in these patients. The latest study appears to endorse the “safe” camp.
Read More

Does CBT Improve Outcome in Buprenorphine Treatment?

March 1, 2017
Colleen Ryan, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Colleen Ryan, MD Dr. Ryan has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Patients receiving buprenorphine for opioid use disorder are typically also referred for psychotherapy, either individual or group. However, several studies have failed to show that therapy improves outcomes in buprenorphine treatment program
Read More

Switching Antidepressants May Be No Better Than Staying the Course

March 1, 2017
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
The Carlat Report Staff
Complementary and alternative medicine is gradually becoming more mainstream, and we covered some of these treatments in a recent issue of TCPR, but we didn’t cover yoga and meditation. Sudarshan Kriya yoga (SKY) is a meditation technique that combines yoga poses, sitting meditation, and breathing exercises.
Read More

CME Post-Test - Street Drugs, CATR, March/April 2017

March 1, 2017
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME credits.
Read More
Previous 1 2 … 5 6 7 8 9 10 11 12 13 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2635946985.jpg
    General Psychiatry

    AI in Practice

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.